Moreover, we further analyzed the relationship between the expression levels of BIRC2 or STAT1 and the clinicopathological characteristics of HCC patients, and found that the expression levels of BIRC2 or STAT1 were significantly associated with the differentiation degree of HCC in patients (P < 0.05, Table 4). Here, BIRC2 is linked to hepatocellular carcinoma.